Back to results
CompletedPhase 2

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

NCT02285920

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The George Washington University

Washington D.C., District of Columbia, United States

+3 additional locations

View on ClinicalTrials.gov
Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial — TrialFind